STIM who sells equipment for Transcranial MRI for depression gets a fee from each use. Their largest customer is Greenbrook. STIM management said February saw an uptick in treatments. Therefore... Greenbrook may be turning the corner toward treatment growth. Let's hope management can watch expenses to make the stock begin to work.
Y
GTMS.TO reached a 52 Week low at 3.52
G
anyone holding this stock ??
P
More emphasis should be put into day tradiing as it is less affected by the unpredictable nature of the market.I have made over 19 btc from day trading with Ivan Patrice insights and signals in less than 4 weeks,this is one of the best medium to backup your assets incase it goes bearish. You can easily get to Ivan Patrice on 🆃🅴🅻🅴🅶🆁🅼: IVANPATRICE for any crypto info.
B
Buy indicator at 1.60 points and currently undervalued. very strong bullish evidence for short and long term. projections are at $3.50 to $4.50. Any thoughts?
E
with 120 treatment centers in US and the addition of Spravato pilot program as a driver for revenue I am imagining some serious upside. Guess the traders are waiting on Nasdaq. Future use of psiloycybin and a further broadening of revenue stream. What's not to like?? GLTA